AbCellera to Present Virtually at the 11th Annual SVB Leerink Global Healthcare Conference on February 17, 2022
February 11 2022 - 4:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that executives from
the Company will present virtually at the 11th Annual SVB Leerink
Global Healthcare Conference on Thursday, February 17, 2022, at
12:40 p.m. Pacific Time.
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc. AbCellera is a technology
company that searches, decodes, and analyzes natural immune systems
to find antibodies that its partners can develop into drugs to
prevent and treat disease. AbCellera partners with drug developers
of all sizes, from large pharmaceutical to small biotechnology
companies, empowering them to move quickly, reduce costs, and
tackle the toughest problems in drug development. For more
information, please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220211005577/en/
Media: Jessica Yingling, Ph.D.; media@abcellera.co,
+1(236)521-6774 Business Development: Neil Berkley;
bd@abcellera.com, +1(604)559-9005 Investor Relations: Melanie
Solomon; ir@abcellera.com, +1(778)729-9116
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbCellera Biologics (NASDAQ:ABCL)
Historical Stock Chart
From Apr 2023 to Apr 2024